{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:01:08Z","timestamp":1783807268997,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-038-041"],"award-info":[{"award-number":["108-2314-B-038-041"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["109TMU-SHH-04"],"award-info":[{"award-number":["109TMU-SHH-04"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.cyto.2020.155353","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T18:53:48Z","timestamp":1603738428000},"page":"155353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Serum interferon levels associated with the disease activity in women with overt Graves' disease"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0466-6630","authenticated-orcid":false,"given":"Chao-Wen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam-Tsun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-8249","authenticated-orcid":false,"given":"Jiunn-Diann","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3-4","key":"10.1016\/j.cyto.2020.155353_b0005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","article-title":"The etiology of autoimmune thyroid disease: a story of genes and environment","volume":"32","author":"Tomer","year":"2009","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.cyto.2020.155353_b0010","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cyto.2020.155353_b0015","first-page":"2563","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"2014","author":"Turner","year":"1843","journal-title":"BBA"},{"key":"10.1016\/j.cyto.2020.155353_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cellimm.2015.01.015","article-title":"Both interleukin-23A polymorphism and serum interlukin-23 expression are associated with Graves' disease risk","volume":"294","author":"Jia","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/cen.12725","article-title":"Genetic association between Interleukin-17A gene polymorphisms and the pathogenesis of Graves' disease in the Han Chinese population","volume":"84","author":"Qi","year":"2016","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.cyto.2020.155353_b0030","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180143","article-title":"Association of TNF-alpha promoter polymorphism and Graves' disease: an updated systematic review and meta-analysis","volume":"38","author":"Tu","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cyto.2020.155353_b0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.15537\/1658-3175.1216","article-title":"Serum cytokines levels in Graves' disease","volume":"21","author":"Al-Humaidi","year":"2000","journal-title":"Saudi Med J"},{"key":"10.1016\/j.cyto.2020.155353_b0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/eje.0.1410111","article-title":"Increased levels of serum interleukin-12 in Graves' disease","volume":"141","author":"Tamaru","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cyto.2020.155353_b0045","first-page":"58","article-title":"Proinflammatory cytokine levels in hyperthyroidism","volume":"26","author":"Senturk","year":"2003","journal-title":"Clin. Invest. Med."},{"issue":"3","key":"10.1016\/j.cyto.2020.155353_b0050","doi-asserted-by":"crossref","first-page":"J322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2020.155353_b0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1410325","article-title":"Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis","volume":"141","author":"Monzani","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cyto.2020.155353_b0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/eci.12463","article-title":"Association of IRF8 gene polymorphisms with autoimmune thyroid disease","volume":"45","author":"Lin","year":"2015","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155353_b0065","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1210\/jcem.84.10.6071","article-title":"The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor","volume":"84","author":"Sanders","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2020.155353_b0070","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"Clinical review 169: interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects","volume":"89","author":"Carella","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cyto.2020.155353_b0075","doi-asserted-by":"crossref","first-page":"e13065","DOI":"10.1111\/eci.13065","article-title":"Associations of secreted phosphoprotein 1 and B lymphocyte kinase gene polymorphisms with autoimmune thyroid disease","volume":"49","author":"Cheng","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cyto.2020.155353_b0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/cen.14090","article-title":"Associations of gene polymorphisms in interferon\u2010alpha signature\u2010related genes with autoimmune thyroid diseases","volume":"91","author":"Lin","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cyto.2020.155353_b0085","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1172\/JCI119455","article-title":"Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy","volume":"99","author":"Genc","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2020.155353_b0090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1084\/jem.20151724","article-title":"B cell IFN-gamma receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6","volume":"213","author":"Jackson","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2020.155353_b0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2017.00119","article-title":"Interferon lambda: modulating immunity in infectious diseases","volume":"8","author":"Syedbasha","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res. Therapy"},{"key":"10.1016\/j.cyto.2020.155353_b0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0531-5565(01)00195-4","article-title":"Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules","volume":"37","author":"Gupta","year":"2002","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.cyto.2020.155353_b0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/thy.2011.0222","article-title":"Relative levels of the inflammatory cytokine TNFalpha and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves' disease","volume":"22","author":"Yamamoto","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.cyto.2020.155353_b0125","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/jcem-70-6-1735","article-title":"Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture","volume":"70","author":"Sato","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2020.155353_b0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0960-5428(97)00027-7","article-title":"Cytokines and thyroid function","volume":"6","author":"Ajjan","year":"1996","journal-title":"Adv. Neuroimmunol."},{"key":"10.1016\/j.cyto.2020.155353_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy","volume":"85","author":"Falini","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2020.155353_b0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2350-13-116","article-title":"Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves' disease and Graves' ophthalmopathy","volume":"13","author":"Tsai","year":"2012","journal-title":"BMC Med. Genet"},{"key":"10.1016\/j.cyto.2020.155353_b0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000289199","article-title":"Type I interferon: a new player in TNF signaling","volume":"11","author":"Yarilina","year":"2010","journal-title":"Curr. Directions Autoimmunity"},{"key":"10.1016\/j.cyto.2020.155353_b0150","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2020.155353_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00199903","article-title":"Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo","volume":"16","author":"Bloksma","year":"1983","journal-title":"Cancer Immunol. Immunotherapy: CII"},{"key":"10.1016\/j.cyto.2020.155353_b0160","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.4049\/jimmunol.181.7.4461","article-title":"IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages","volume":"181","author":"Vila-del Sol","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0165","first-page":"1462","article-title":"Interleukin-2 and autoimmune disease occurrence and therapy","volume":"16","author":"Geng","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cyto.2020.155353_b0170","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0264-410X(02)00101-9","article-title":"Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques","volume":"20","author":"van der Meide","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2020.155353_b0175","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2020.155353_b0180","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","article-title":"A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R","volume":"168","author":"Parham","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","article-title":"Matrix metalloproteinases as modulators of inflammation","volume":"19","author":"Manicone","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cyto.2020.155353_b0190","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(84)92506-6","article-title":"Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis","volume":"1","author":"Brown","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2020.155353_b0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2020.155353_b0200","doi-asserted-by":"crossref","first-page":"683739","DOI":"10.1155\/2015\/683739","article-title":"Serum osteocalcin is associated with inflammatory factors in metabolic syndrome: a population-based study in chinese males","volume":"2015","author":"Liao","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2020.155353_b0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.17219\/acem\/68991","article-title":"Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves' orbitopathy","volume":"27","author":"Kapelko-Slowik","year":"2018","journal-title":"Adv. Clin. Exp. Med.: Off. Organ Wroclaw Medical University"},{"key":"10.1016\/j.cyto.2020.155353_b0210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03348786","article-title":"Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis","volume":"15","author":"Kojima","year":"1992","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.cyto.2020.155353_b0215","doi-asserted-by":"crossref","first-page":"e0144599","DOI":"10.1371\/journal.pone.0144599","article-title":"The presence of thyroid-stimulation blocking antibody prevents high bone turnover in untreated premenopausal patients with Graves\u2019 disease","volume":"10","author":"Cho","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2020.155353_b0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/08916930310001603046","article-title":"Cytokines in thyroid autoimmunity","volume":"36","author":"Ajjan","year":"2003","journal-title":"Autoimmunity"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620303690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:19:56Z","timestamp":1777605596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620303690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"alternative-id":["S1043466620303690"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155353","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum interferon levels associated with the disease activity in women with overt Graves' disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155353"}}